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ABSTRACT: Antimicrobial silver nanoparticle coatings have attracted
interest for reducing prosthetic joint infection. However, few studies report
in vivo investigations of the biotransformation of silver nanoparticles within
the regenerating tissue and its impact on bone formation. We present a
longitudinal investigation of the osseointegration of silver nanoparticle-coated
additive manufactured titanium implants in rat tibial defects. Correlative
imaging at diﬀerent time points using nanoscale secondary ion mass
spectrometry, transmission electron microscopy (TEM), histomorphometry,
and 3D X-ray microcomputed tomography provided quantitative insight from
the nano- to macroscales. The quality and quantity of newly formed bone is
comparable between the uncoated and silver coated implants. The newly
formed bone demonstrates a trabecular morphology with bone being located
at the implant surface, and at a distance, at two weeks. Nanoscale elemental
mapping of the bone−implant interface showed that silver was present
primarily in the osseous tissue and colocalized with sulfur. TEM revealed silver sulﬁde nanoparticles in the newly regenerated
bone, presenting strong evidence that the previously in vitro observed biotransformation of silver to silver sulﬁde occurs in vivo.
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1. INTRODUCTION
Additive manufactured (AM) open-porous titanium implants1,2
are increasingly used in orthopedic applications where bone
ﬁxation and load bearing are required. These open-porous
implants allow desirable early bone ingrowth3 and more rapid
osseointegration.4,5 Unfortunately, the placement of prostheses
is also associated with the risk of prosthetic joint infection
(PJI),6,7 ultimately leading to delayed healing or implant failure.
It has been estimated that 2.5% of patients with primary knee
and up to 20% of revision knee replacements have been aﬀected
by PJI.8,9 Treatment of such infection with antibiotics proves to
be ineﬀective due to bioﬁlm formation with the ability of the
immune system to respond also being hampered.10,11 There-
fore, an antimicrobial surface aimed at preventing the bacterial
colonization and bioﬁlm formation during surgery and in the
immediate postoperative period is highly desirable.
Silver-based antimicrobials are of particular interest due to
their broad antimicrobial spectrum and eﬃcacy,12,13 allowing
them to inhibit both Gram-positive and Gram-negative bacteria
with very low silver concentrations. Nanoscale silver (nano-Ag)
such as silver nanoparticles (AgNPs) is more reactive than its
bulk counterparts due to the large surface area-to-volume
ratio.14 The interaction of AgNPs with moisture and body ﬂuid
leads to the fast release of biologically active silver ions,15
binding to bacterial protein or DNA16 and thereby preventing
bacterial adhesion and bioﬁlm formation. In addition, ultrathin
AgNP ﬁlms have been successfully incorporated onto non-
planar surfaces and complex architectures by several
techniques.17−19 Atomic layer deposition (ALD), a sequential
and self-limiting process, provides a number of advantages for
depositing an AgNP surface layer, including texturing and
biocompatibility. The sub-angstrom control of silver deposition
coupled with the self-saturating reaction lead to the formation
of uniform sized AgNPs coated onto the additive manufactured
porous titanium.17 In a previous study, ALD of silver coated Ti
implants was shown to be eﬀective in reducing major
pathogenic bioﬁlm formation in vitro.20
The remarkable antimicrobial eﬀects of AgNPs have led to
their application in a diverse range of orthopedic implants.
However, the close contact that exists between silver coated
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implants and bone21 also raises concerns regarding the
potentially harmful eﬀect associated with the uptake of the
silver ions into bone and surrounding soft tissue.22 AgNPs can
readily penetrate the cell membrane,23 releasing ions locally to a
speciﬁc tissue24 and becoming internalized.25,26 Therefore, a
detailed study on the impact of AgNPs is required.
Considerable eﬀort has been expended in examining the
biological eﬀect of silver on bone using a variety of cell lines,
and it has been shown that the impact of AgNPs is both
size-27,28 and dose-dependent.29−33 These in vitro studies
provide an understanding of silver interaction with the speciﬁc
cell types involved in bone healing, revealing a potential
reduction in possible harmful eﬀects by controlling the initial
total amount of silver. Further, recent in vitro evidence suggests
that the silver undergoes sulﬁdation to silver sulﬁde34 through
complex interactions with protein (serum) and cells.35 This
lead to the hypothesis that the biological toxicity of silver is
reduced through the biotransformation of silver into silver
sulﬁde, a more stable and less toxic compound.35 However, the
cellular response triggered by silver and its sulﬁdation to silver
sulﬁde in vitro cannot be directly used to predict tissue level
response in vivo. Bone healing, when augmented by implants, is
characterized by complex interactions between multiple cell
types and the osteoconductive properties of the material,36−39
all of which could be disrupted by silver.
In the majority of prior studies, there is a lack of information
dealing with the harmful eﬀects of silver on bone regeneration
with apparent inconsistencies in the results obtained. Korani et
al.40 observed an abnormal inﬂammatory response in lamellar
bone following the dermal exposure of silver. On the contrary,
Marsich et al.41 found comparable bone healing patterns
without signiﬁcant diﬀerence in bone contact. These contra-
dictory results may be explained by the diﬀerences in routes of
exposure (e.g., bone contact, blood contact, or inhalation) and
experiment end-point, inevitably raising doubts about whether
silver coating is detrimental to bone healing.
To date, only a few studies have focused on the eﬀect of
silver on bone regeneration associated with implanted
materials.41,42 However, none have performed investigations
examining multiple time-points during incorporation of im-
plants nor have they assessed the uptake/distribution of silver
in tissue upon release from an implant. These aforementioned
experiments can provide particularly useful information
regarding the possible biological eﬀect of silver on bone
healing and potential target tissue following the contact of new
bone and silver coated devices, respectively. For these reasons,
detailed in vivo studies are required to fully elucidate the impact
of silver on bone healing.
In the present study, the quantity and quality of bone
following surgical implantation of both silver coated and
uncoated titanium scaﬀolds were assessed using both X-ray
microcomputed tomography (μCT) and histological measure-
ments. The impact of silver coating was assessed after 2, 6, and
12 weeks in vivo to identify whether the presence of silver
aﬀects bone healing or decreases new bone generation. The
distributions of released silver (107Ag−) in addition to 12C−,
40Ca16O−,31P12C−, and 32S− within adjacent tissues were
quantiﬁed using nanoscale secondary ion mass spectrometry
(NanoSIMS). Transmission electron microscopy (TEM) and
selected area electron diﬀraction (SAED) were combined to
examine the newly formed bone. Correlative imaging was used
to combine all of these complementary techniques to
investigate the bone−implant interface and the biotransforma-
tion of the silver.
2. MATERIALS AND METHODS
2.1. Fabrication and Preparation of the Open-Porous
Implants. Open-porous titanium implants were fabricated by additive
manufacturing as previously described.43 Brieﬂy, cylindrical shaped
titanium implants of 2.5 mm diameter and 1.5 mm height, as shown in
Figure 1a, were produced using a MCP Realizer 250 selective laser
melting (SLM) system (MCP Tooling Technologies, Lubeck,
Germany). The basic material used to fabricate implants was grade
1 commercially pure titanium (CP-Ti) powder with a modal particle
diameter of 28.5 μm (Sumitomo Corp., Tokyo, Japan).43 The powder
layer thickness used in the build process was 50 μm.43 The open-
porous implants were made with a nominal porosity of 65% and a strut
diameter of 180 μm.2
Following the SLM build process, the implants were cleaned in an
ultrasonic bath (VWR, Radnor, United States) with micro-90
detergent (Decon, Sussex, UK) diluted 1:20 in distilled water to
remove unfused powder. The samples were then rinsed in distilled
water and dried. Once cleaned, the samples were subject to heat
treatment in an inert atmosphere at 667 Pa and 1400 °C (for 3 h).
Before atomic layer deposition, the sintered implants were once again
sintered and cleaned using the process described above.
2.2. ALD of the AgNP Coating. Surface modiﬁcation of the
implant samples with an ultrathin layer of silver was carried out using
direct liquid injection ALD in a customized Aixtron AIX 200FE AVD
reactor.20 The ALD process used has been shown to be controlled by
self-limiting surface reactions, enabling the production of highly
conformal nanotextured metallic silver ﬁlms on complex three-
dimensional structures.44,17 The organometallic precursor and
c o r e a c t a n t u s e d i n t h e d e p o s i t i o n p r o c e s s w a s
(hexaﬂuoroacetylacetonato)silver(I)(1,5-cyclooctadiene) dissolved in
a 0.1 M anhydrous toluene solution (Sigma-Aldrich, Germany) and
propan-1-ol (HPLC grade/Fisher, Leics, UK), respectively. Each ALD
cycle consisted of a 4 step process, starting with a 4 s dose of the silver
precursors, followed by an 8 s argon (99.999%; BOC, UK) purge, a 4 s
propan-1-ol dose, and ﬁnally another 8 s argon purge. The silver
precursor solution was introduced into the reactor using direct liquid
Figure 1. (a) Macroscopic SEM-SE image of the additively
manufactured porous titanium scaﬀold. High-resolution SEM images
of (b) titanium scaﬀolds and (c) silver coated titanium scaﬀolds. (d)
Size distribution histogram of silver particles (125 °C for 500 ALD
cycles).
ACS Applied Materials & Interfaces Research Article
DOI: 10.1021/acsami.7b05150
ACS Appl. Mater. Interfaces 2017, 9, 21169−21180
21170
injection at a rate of 17.5 μL/s and was volatilized at 130 °C, while the
propan-1-ol was delivered into the reactor from a vapor-draw bottle
held at room temperature (∼20 °C) using a Swagelok ALD valve.
Each sample was coated using 500 ALD cycles to give a nominal ﬁlm
thickness (if uniform rather than particulate islands) of ∼13 nm, which
corresponds to a rate of 0.026 nm/cycle.
2.3. Scanning Electron Microscopy. The structure of the Ti and
Ti−Ag implants was characterized by scanning electron microscopy
(JEOL JSM-7001F FEG-SEM, Tokyo, Japan) in secondary electron
mode using a 10 kV accelerating voltage.
2.4. Sterilization. Before implantation, all samples were soaked in
ethanol for 2 h before sterilization with ultraviolet (UV) light in a
Class II biosafety cabinet (Esco, Canada).45
2.5. Surgical Implantation. A total of 36 adult male Wistar rats,
10−12 weeks old and weighting 300−400 g, were used for the in vivo
study. The experimental protocol was approved by the institutional
animal care committee at the University of Ulster and National (UK
Home Oﬃce) guidelines. In brief, an anesthetic drug (2.0 mL Ketaset,
100 mL/mg) and 1.0 mL Xylapan (20 mL/mg) diluted in 5 mL
phosphate buﬀered saline (PBS) (pH 7.4, 0.5 mL/100 g) was injected
to sedate the animals. For the surgical procedures, a 2.5 mm subcritical
size defect was created using a trephine bur. The circular defect
penetrated well into the marrow cavity. Rats were randomly divided
into two groups of 18 rats each implanted with titanium (Ti) or silver
coated titanium implants (Ti−Ag).
After healing periods of 2, 6, and 12 weeks, the animals were
sacriﬁced, and the implanted tibiae were subsequently ﬁxed in a
solution of 10% buﬀered formal saline for X-ray μCT scanning.
2.6. Ex Vivo X-ray μCT. 2.6.1. Image Acquisition. Post-
implantation, all implanted tibiae (n = 36) were wrapped in Paraﬁlm
M (Bemis, United States) and placed in an ABS plastic tube. The
scanning was performed using a laboratory-based μCT system
(Nanofocus, Phoenix|X-ray General Electric Company, Measurement
and Control, Wunstorf, Germany). To reduce beam hardening
artifacts,37 the μCT scanner was operated at 85 kV and 111 μA with
a 0.5 mm-thick copper ﬁlter. Images were reconstructed using the
Datos|x software (Phoenix|X-ray), resulting in an image matrix of 990
× 990 × 1000 pixels with an isotropic voxel size of 5 μm. The
reconstructed images were subsequently analyzed in Avizo software
(Avizo 8.0, FEI Visualization Sciences Group, Meŕignac Cedex,
France) and Matlab (Mathworks Inc., Natick, Massachusetts, United
States).
2.6.2. Segmentation. The segmentation procedure comprised an
image ﬁlter, a global threshold, and a local thresholding method.46 In
the ﬁrst pass, the reconstructed data were normalized to a
predetermined reference histogram before undergoing smoothing
ﬁlters (edge preserving ﬁlter and anisotropic diﬀusion ﬁlter)47 to
reduce the inﬂuence of noise and artifacts. The ﬁltered images were
ﬁrst presegmented into a “mask” containing bone and implant areas
using an Ostu algorithm.46 After presegmentation, the bone was
segmented from the implant area using local thresholding.46 The
boundary between the bone and implant was smoothed using the
morphological operations of erosion (by one pixel) and dilation (by
one pixel).
2.6.3. Quantiﬁcation of the Titanium Scaﬀold and Newly
Formed Bone. After segmentation, the bone and titanium phases
from each individual sample were registered with a high resolution
tibia shape model and a cylindrical mask (2.5 mm in diameter and 1.5
mm in height), respectively. The overlapping of the shape model and
cylindrical mask were used to generate the region of interest (ROI) in
a reproducible fashion (Figure 2a). Microarchitectural parameters (1)
bone ingrowth (BI) [(bone area/ROI) × 100%], (2) bone contact
(BC) [(bone contact area/total scaﬀold area) × 100%), (3) speciﬁc
surface area (SSA) [(bone area/bone volume) × 100%], (4) bone
trabecular thickness (Tb.Th), and (5) trabecular separation (Tb.Sp)48
of the newly formed bone were analyzed within the deﬁned ROI. Strut
thickness and porosity of the titanium scaﬀolds were measured.2,49
2.7. Histology and Histomorphometry. Histological prepara-
tion of rat tibiae containing titanium implants has been previously
described in detail.50 Brieﬂy, 18 tibial specimens containing the
implants (n = 3 at 2, 6, and 12 weeks in the Ti and Ti−Ag groups)
were decalciﬁed, dehydrated, inﬁltrated and embedded in LR white
resin (TAAB Laboratories Equipment Ltd., Berks, UK). The
polymerized blocks were trimmed of excess resin and glued onto
plastic microscope slides (EXAKT, Oklahoma City, United States). An
EXAKT Vacuum Adhesive Press was used to mount the samples for
UV treatment (5 min). Subsequently, one-half of the samples were cut
approximately from the center of the Ti implant using an EXAKT 310
Macro Band System with a diamond blade (EXAKT). The blocks were
ground successively with K800, K2500, and K4000 grinding paper
(EXAKT) using an EXAKT 400CS grinding system to yield ∼50−100
μm-thick sections. Finally, the sections were stained with Gill’s
Haematoxylin III (Fisher Scientiﬁc, Loughborough, UK) and multiple
staining solution before examination on a Zeiss Axiophot microscope
(Zeiss; Wetzlar, Germany). Histomorphometric analysis of new bone
consisted of a quantitative assessment of the BI.
2.8. Sample Preparation for Spectroscopic Analyses. Four
nondecalciﬁed samples of tibia with implant (n = 1 at 2 weeks in the Ti
group; n = 1 at 2, 6, and 12 weeks in the Ti−Ag group) were washed
in distilled water and kept in a −80 °C freezer (New Brunswick
Figure 2. (a) X-ray μCT images of bone formation within the ROI.
Bone ingrowth was quantiﬁed at (b and c) 2, (d and e) 6, and (f and
g) 12 weeks postoperation. Arrows indicate the newly regenerated
bone in the uncoated (green) and silver coated group (red). (h) The
amount of bone ingrowth, expressed as the percentage bone volume
within ROI as measured by μCT. Statistical signiﬁcance (*) was
considered where p < 0.05. Scale bars are 500 μm.
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Scientiﬁc, Enﬁeld, United States) for 48 h. The frozen samples were
then freeze-dried in a CoolSafe 100-4 freeze-drier (Scanvac-Coolsafe,
Lynge, UK) for 48 h. At the end of the drying cycle, bone−implant
samples were mounted in LR white resin (Sigma-Aldrich, Dorset, UK)
and polished to a mirror ﬁnish using 1 μm diamond suspension paste
(Struers, Glasgow, UK). Immediately before NanoSIMS analysis, the
embedded samples were coated with 10 nm of platinum.
2.9. NanoSIMS. NanoSIMS images of the bone implant samples
were acquired using a CAMECA NanoSIMS 50L instrument (Cameca,
Gennevilliers Cedex, France). A 16 keV Cs+ primary ion beam with a
current of 1.8−2.6 pA was scanned over the surface to generate
negative secondary ions. The instrument was calibrated using
standards of high concentration to detect 12C−, 32S−, 31P12C−,
40Ca16O−, 48Ti16O−, and 107Ag−. To ensure that each imaged area
was at steady state and to remove the platinum coating, Cs+ ions were
implanted into the surface to achieve a dose of 1 × 1017 ions cm−2. Six
to eight regions of interest were imaged from each sample with an area
of 50 × 50 μm2 (512 × 512 pixels). A dwell time of 5000 μs/pixel was
used with an aperture size of 300 μm (D1 = 2). Image processing was
carried out using ImageJ software (United States National Institutes of
Health, Bethesda, Maryland, United States) with OpenMIMS plugin
(National Resource for Imaging Mass Spectrometry, Cambridge,
Massachusetts, United States).
2.10. Sample Preparation for Correlative Imaging. After the
NanoSIMS experiments, the surface that was analyzed with NanoSIMS
was polished using a 6 μm diamond suspension (Struers, Glasgow,
UK) and glued onto a glass slide (Thermo Scientiﬁc, Hudson, United
States). The other side of the sample was further ground using K1200
and P4000 grinding paper (Struers, Glasgow, UK) until the sample
was 70−90 μm thick. These sections were stained with Goldners
Trichrome (method adapted from ref 51). Brieﬂy, the sections were
rinsed with distilled water for 15 min, and the nuclei were stained for
20 min using Weigert’s Haematoxylin (Sigma-Aldrich, Dorset, UK).
The sections were then rinsed with distilled water and stained with
0.01% azophloxine for 15 min. Sections were then rinsed with 1%
acetic acid followed by staining with 2% Orange G for 3 min and
rinsed again with 1% acetic acid. Lastly, they were stained with 0.2%
Light Green for 5 min followed again by rinsing with 1% acetic acid for
5 min. The sections were then blotted dry and imaged using Olympus
SZX16 stereoscopic microscope at a range of magniﬁcations. The
histological appearance of tissues in the images is consistent with
mineralized bone staining green/dark green and ﬁbrous tissue as
orange/orange red.
1.11. TEM Imaging. The Goldners trichrome stained histological
sections were polished to ∼30 μm using P4000 grinding paper
(Struers, Glasgow, UK). The section was then mounted in a 3.05 mm
Cu folding grid with a 1 mm circular hole in the center (Agar
Scientiﬁc, UK). To thin the section to electron transparency a
Fischione 1050 Ar+ mill was used. Thinning was performed at
successively lower beam energies and shallower angles (with respect to
the section plane). Initial beam conditions were 10 kV and ±10°. Final
thinning conditions were 4 kV and ±6°.
To diﬀerentiate the bone and ﬁbrous tissue, the ion beam milled
bone implant sample was imaged using a stereoscopic microscope
(Olympus SZX16) at a range of magniﬁcations. The sample was then
imaged using a JEOL 2100 TEM operated at 200 kV. Images and
diﬀraction patterns were acquired up to ∼5 μm from the implant
surface. For imaging, a 1 s camera exposure time was used. For
diﬀraction patterns, a ∼0.4 μm SA aperture and a 5 s camera exposure
time were used.
2.12. Statistical Analyses. The results from μCT (n = 6) and
histomorphometry analysis (n = 3) are presented as mean ± standard
deviation. Statistical comparisons were performed with a Mann−
Whitney U test. All statistical analysis was carried out using XLSTAT
(Addinsoft, Inc., United States) with statistical signiﬁcance considered
when p < 0.05(*).
3. RESULTS
3.1. Characterization of the Open-Porous Titanium
Implants. The Ti implants (Figure 1a) were found to have a
porosity of 67 ± 5%, and the modal strut diameter was 170 ±
20 μm. This compares favorably with the original design, which
aimed to have 65% porosity and 180 μm struts.2 The selective
laser melting (SLM) of the pure Ti powders gives rise to
scaﬀolds (Figure 1b) with a rough surface, irregular shape, and
a large surface area. During the ALD deposition process,
metallic AgNPs (Figure 1c) are uniformly deposited on the
porous Ti surface. From the size distribution histogram (Figure
1d), an average particle size of 49 ± 3 nm could be estimated.
3.2. Analysis of Quantity of Bone Using Ex Vivo X-ray
Microcomputed Tomography. 3.2.1. Bone Ingrowth.
Three-dimensional μCT analysis of the entire implant was
performed on 2, 6, and 12 week samples of rat tibia containing
titanium scaﬀolds to assess bone ingrowth in a predeﬁned ROI
(Figure 2a). Representative μCT images (Figures 2b−g)
qualitatively conﬁrm bone formation progresses over time for
both the uncoated and silver coated titanium scaﬀolds. New
bone was observed at the edge and interior of the defect site at
2 weeks after implantation with 35 ± 10 and 31 ± 5% of void
space being replaced by irregular immature bone (Figures 2b
and c). At 6 weeks postimplantation, a higher proportion of
new bone was detected along the porous titanium implant from
the surface to the center (Figures 2d and e). After 12 weeks, the
implant pores were almost completely ﬁlled by newly formed
bone (Figures 2f and g). The results of the quantitative data
measured from μCT are summarized in Table 1 and Figure 2h.
No diﬀerence in bone ingrowth was observed between the Ti
and Ti−Ag groups. There were signiﬁcant statistical diﬀerences
in bone ingrowth between 2 and 6 weeks and 2 and 12 weeks
postimplantation (p = 0.002 and 0.001, respectively).
3.2.2. Bone Contact. The contact area in the Ti (green) and
Ti−Ag (red) groups were shown in 3D (Figure 3a−f). An
increase in bone contact length was observed as the healing
period increased (from 2−12 weeks postimplantation) in both
groups. The BC of the Ti (56 ± 10%) and the Ti−Ag group
(44 ± 13%) at 6 weeks’ postimplantation was signiﬁcantly
higher than at 2 weeks postimplantation (20 ± 6 and 14 ± 5%)
(p < 0.05). After 12 weeks implantation, up to 82% of the
implant surface was colonized by newly formed bone.
Signiﬁcant diﬀerences in BC were not observed between the
titanium and silver coated groups. The quantitative measure-
ments of the BC for both groups are summarized in Table 1
and Figure 3g.
Table 1. BI and BC Measured from μCT and Histology
Ti Ti−Ag
μCT histology μCT histology
time (weeks) BI (%) BC (%) BI (%) BI (%) BC (%) BI (%)
2 35 ± 10 20 ± 6 31 ± 9 31 ± 5 14 ± 5 29 ± 8
6 66 ± 6 56 ± 10 42 ± 7 58 ± 7 44 ± 13 59 ± 15
12 76 ± 7 71 ± 11 77 ± 6 74 ± 6 73 ± 9 66 ± 10
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3.2.3. Bone Morphometric parameters. We observed an
increase in Tb.Th and a decrease in SSA and Tb.Sep as the
healing period increased in both groups (Figure 4 and Table 2).
The thickness of the newly formed bone was increased between
2 and 6 weeks and 2 and 12 weeks (p < 0.05). No signiﬁcant
diﬀerences in SSA, Tb.Th, or Tb.Sep were found between the
uncoated and silver coated titanium groups. There was a
signiﬁcant decrease in SSA between 2 and 6 weeks and 2 and
12 weeks (p < 0.05). In the titanium implant, there were
signiﬁcant increase between 2 and 6 weeks (62 ± 8 and 102 ±
17 μm, p < 0.05) and 2 and 12 weeks (62 ± 8 and 122 ± 28
μm, p < 0.05) respectively for Tb.Th. In the silver coated
titanium implant, the increase in Tb.Th was observed only
between 2 (62 ± 24 μm) and 12 weeks (129 ± 25 μm).
3.3. Quality of Newly Formed Bone Using Histology
and Histomorphometry. In the 2 week samples from the Ti
and Ti−Ag groups, newly formed bone is seen on both the
periphery of the defect as well as the surface of the implant,
where trabecula tended to be smaller in diameter and
composed of woven bone (Figures 5a and b). At 6 weeks’
postimplantation, lamellar bone is more conspicuous (Figures
5c and d). By 12 weeks, the gap between the implant and defect
further decreased, and lamellar bone predominated (Figures 5e
and f).
The histomorphometrical assessment of BI in the Ti and Ti−
Ag group is summarized in Figure 5g and Table 1. In both
groups, BI increased signiﬁcantly between 2 and 12 weeks
postimplantation (p < 0.05).
3.4. Elemental Mapping of Newly Formed Bone Using
NanoSIMS. NanoSIMS analysis of the samples revealed local
element distributions at the bone−implant interface at two
weeks postimplantation in both the Ti (Figures 6a−e) and Ti−
Ag groups (Figures 6f−j). Brighter regions of the images
indicate higher counts for that elemental signal. Strong
40Ca16O−, 31P12C−, and 32S− signals were observed in the
bone tissue; 48Ti16O− signals were highest from the titanium
implant, and 12C− was observed in certain areas at the bone−
implant interface and presumably originates from organic
fragments in the bone as well as the resin.
The heterogeneous distribution of 40Ca16O− and 31P12C−
(Figures 6c−d and h−i, respectively) observed at 2 weeks’
postimplantation over the trabecular network, represents a
diﬀerent degree of maturity of the newly formed bone. Bone
growth in direct contact along the entire surface of the implant
(contact osteogenesis) was observed in both groups, revealing
osseointegration at early time points (Figures 6c and h).
The NanoSIMS elemental maps of 48Ti16O−, 40Ca16O−, 32S−,
and 107Ag− signals are given in Figure 7. The maps demonstrate
the distribution of Ti (Figure 7i), Ca (Figure 7ii), S (Figure
7iii), and Ag (Figure 7iv), while the merged images (Figure 7v)
of Ti, Ca, and Ag at the implant interface for 2 weeks for Ti and
2, 6, and 12 weeks for Ti−Ag show the interactions. As before,
Figure 3. μCT images of bone to titanium scaﬀold contact with and
without silver coating at (a and b) 2, (c and d) 6, and (e and f) 12
weeks postimplantation. (g) Bone contact, expressed as the percentage
of bone implant contact within the ROI as measured by μCT.
Statistical signiﬁcance (*) was considered where p < 0.05. Scale bars
are 500 μm.
Figure 4. Bone morphometric parameters. (a) SSA, (b) Tb.Th, and
(c) Tb.Sep as measured by μCT. Representative μCT images are inset
in panel a. Statistical signiﬁcance (*) was considered where p < 0.05.
Scale bars are 200 μm.
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Ca and S intensities are highest at the bone tissue. Silver was
detected in the Ti−Ag samples at all time points (Figures 7b−
d(iv). The merged images (Figure 7v) reveal that silver is
slowly released from the implant surface, as expected, but
interestingly, some becomes conﬁned within the newly formed
osseous tissue. Furthermore, colocalization of silver and sulfur
was observed, where the silver signal indicated by red arrows in
Figures 7b−d(iv) was highest in regions with the high intensity
sulfur signal (yellow arrows in Figures 7b−d(iii). Additionally,
2 weeks postimplantation, silver in the osseous tissue was
observed both at the surface of the implant as well as in the
trabecula away from the implant. But at 6 and 12 weeks, silver
was found only at the bone attached to the surface of the
implant (yellow arrowhead in Figure 7d(iii), red arrowhead in
Figure 7d(iv)).
3.5. Correlative Imaging Using μCT, Histology, and
NanoSIMS. Correlative multimodal imaging was used to
quantify bone tissue within the whole defect site, to identify
diﬀerent tissues present in the bone-tissue interface, and to
visualize their elemental makeup.
At 2 weeks postimplantation, the trabecular structure of the
newly formed bone is clearly observed in the μCT image
(Figure 8a). The histology image (Figure 8b) shows both the
woven bone (green/dark green) and ﬁbrous tissue (orange).
The inset of histology (Figure 8b) shows a high magniﬁcation
image of a 50 μm2 region, and the corresponding NanoSIMS
images of this region are shown in Figures 8c−g, revealing the
Ti, Ca, S, and Ag maps within the implant and the newly
formed tissue. Calcium and sulfur are observed in the newly
formed bone, colocalized with silver content (107Ag−) both near
and distant from the implants.
At 12 weeks postimplantation, the void space around the
porous implant is ﬁlled by newly formed bone with signiﬁcantly
increased thickness revealed by the μCT image (Figure 8h). A
region of less attenuating tissue was observed at the bone−
implant interface (white arrowhead) which, when correlated to
the magniﬁed histology image (Figure 8i), reveals that ﬁbrous
tissue is still present at the interface. The colocalization of silver
and sulfur in NanoSIMS images is observed only at the region
near the bone−implant interface (Figures 8c−g).
3.6. TEM and SAED. TEM images and SAED patterns were
collected from the bone implant interface region. Figure 9a
shows a low magniﬁcation image of a region of silver coated
titanium scaﬀold with tissue attached to the surface of the
implant. The dotted purple line delineates the interface
between titanium implant and tissue. Inset of Figure 9a
shows the histological image of an electron transparent tissue
region near the silver coated implants. Both bone (green) and
ﬁbrous (orange) tissues were identiﬁed in close proximity to
each other adjacent to the implant surface. TEM micrographs
from the bone region (white box, inset in Figure 9a) shows the
distinctive ∼10 nm width ﬁbrillar structures (yellow arrows,
Figures 9b and c) with particles (red arrows, Figures 9b and c)
within these areas. Electron diﬀraction pattern (Figure 9d)
from the area bounded by the circle reveals the crystalline
nature of the sample.
4. DISCUSSION
Prosthetic joint infection (PJI) remains a serious complication
after orthopedic surgery, which has led to a number of
approaches being developed to modify bacterial adhesion and
growth on the surfaces of implanted devices. AgNPs are
eﬀective in preventing bacterial adhesion, bioﬁlm formation,
and subsequent PJI.14,16,20 An investigation by Liu et al.63 into
in vitro dissolution of AgNPS in biological medium showed a
fast silver release proﬁle up to 12 h of incubation; this is the
most critical period for the development of PJI (from the time
of surgery). However, AgNPs are also known to be cytotoxic in
vitro27,29,31,33 and at high concentrations have neurotoxic
eﬀects in vivo.52 A previous study20 on AgNP coated titanium
Table 2. Bone Morphometric Parameters Measured from X-ray μCT
Ti Ti−Ag
time (weeks) SSA (μm−1 ‰) Tb.Th (μm) Tb.Sep (μm) SSA (μm−1 ‰) Tb.Th (μm) Tb.Sep (μm)
2 65 ± 6 62 ± 8 139 ± 21 58 ± 7 62 ± 24 163 ± 37
6 23 ± 2 102 ± 17 109 ± 20 29 ± 2 92 ± 9 121 ± 44
12 21 ± 3 122 ± 28 108 ± 16 19 ± 3 129 ± 25 120 ± 30
Figure 5. Representative histology images of hematoxylin and multiple
stained bone−titanium implant sections at (a and b) 2, (c and d) 6,
and (e and f) 12 weeks postimplantation. (g) Bone ingrowth in Ti and
Ti−Ag groups (n = 3) is measured from histomorphometry. Statistical
signiﬁcance was considered where p < 0.05. Scale bars are 200 μm.
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Figure 6. NanoSIMS elemental images of bone−implant interface in (a−e) titanium and (f−j) silver coated titanium implants after two weeks of
implantation. The NanoSIMS images (50 × 50 μm2) were acquired using CAMECA NanoSIMS 50L instrument equipped with Cs+ primary ion
beam. Images reveal the colocalization of sulfur (measured as 32S−) and Ca/P (measured as 40Ca16O− and 31P12C−, respectively). The arrows
highlight the direct contact between the newly formed osseous tissue (measured as 40Ca16O− and 31P12C−, respectively) and implants (measured as
48Ti16O−) in both groups. Scale bars are 10 μm.
Figure 7. NanoSIMS elemental images of bone−implant interface after (a and b) 2, (c) 6, and (d) 12 weeks of implantation. The NanoSIMS images
of 48Ti16O− (i), 40Ca16O− (ii), 107Ag− (iii), 32S− (iv), and merged (v) (superposition of 48Ti16O−, 40Ca16O−, and 107Ag−) were used to determine the
uptake of silver. A comparison of images in Ti and Ti−Ag groups at 2 weeks postimplantation (aii, aiv, bii, biv) reveals that the silver (measured
as107Ag−) is taken up into the osseous tissue (measured as 40Ca16O−). At 2 weeks postimplantation, the NanoSIMS images of 107Ag− (red arrows)
and 32S− (yellow arrows) reveal the colocalization of silver and sulfur in the newly formed bone. At 6 and 12 weeks postimplantation, colocalization
of 107Ag− (red arrowhead) and 32S− (yellow arrowhead) is observed only at the region near the periphery of the implant. Scale bars are 10 μm.
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implants showed reduced bacterial (Staphylococcus epidermidis)
recovery and bioﬁlm formation in vitro. It also showed
qualitatively in vivo bone formation and neovascularization
within the pores of the implants. Although several studies have
reported the use of silver coated devices for orthopedic
applications, the uptake/distribution of silver in tissue upon
release from an implant and its impact on new bone formation
is poorly studied. As nanoscale silver is readily ionized and
bioavailable, there is a need to understand the uptake by local
osteogenic cells and potentially harmful eﬀects of silver on bone
formation. The present study quantiﬁes the impact of AgNP
coating on bone formation in addition to determining the
nanoscale distribution of silver within tissues adjacent to the
AM implant.
AgNPs, via the tissue ﬂuid mediated release of metallic silver
particles or Ag+ ions,23,29 are known to be involved in the
generation of reactive oxygen species,31 apoptosis,28 as well as
replacing ions that are essential for cellular function (e.g., Ca2+
and Mg2+).33 In the present study, we describe a selective laser
melted porous Ti scaﬀold on which a uniform and metallic
nanoparticulate Ag coating was deposited by ALD.17 Ultra-
structural examination of the coating revealed discrete and
narrow size distributions (49 ± 3 nm) with no discernible
particle aggregation (Figures 1c and d). Growth of ultrathin Ag
ﬁlms (nominal thickness 13 nm, if it were uniform rather than
Figure 8. (a−n) Correlative imaging of μCT, Goldners trichrome stained histology, and NanoSIMS show diﬀerent tissue types and the uptake of
silver. At 2 weeks postimplantation, the newly formed bone is observed in both (a) μCT and (b) histology images. Correlative (b) histology and (c−
g) NanoSIMS images show the woven bone and ﬁbrous tissue at the bone−implant interface. The colocalization of silver and sulfur occurs in the
newly formed woven bone. At 12 weeks postimplantation, the void space of the porous implant is ﬁlled with more matured bone, as shown in (h) the
μCT image. Correlative (i) histology and NanoSIMS images (j−n) show the lamellar bone and ﬁbrous tissue at the bone−implant interface.
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particulate islands) allows near atomic scale control over the
particle size as well as the total amount of silver in the coating.
The impact of AgNPs on biological behavior is both size27,53
and dose-dependent;29−31 these results coupled with the
complex 3D geometries required for a range of orthopedic
implants necessitates an exacting atomic scale control of the
silver deposition that can be readily achieved with the ALD
process.
Implants and the Extent of Osteogenesis. Here, we
show by multimodal correlative imaging techniques and
quantitative histological studies at the 2 week time point an
equivalent extent of bone ingrowth into the implanted Ti and
Ti−Ag scaﬀolds. Speciﬁcally, after 2 weeks, bone ingrowth was
observed both within the surface of the scaﬀold as well as the
MC (Figures 2a and b). Normal bone healing is largely
mediated by osteogenic cells (principally osteoblasts and
osteoclasts) in addition to mesenchymal stem cells provided
by the adjacent periosteum and marrow cavity.54 In the 6 and
12 week samples, less newly formed bone was detected within
the marrow cavity (Figures 2c−5f), most likely mediated by
osteoclastic resorption on the inner surface of the regenerated
cortical bone.55
μCT and histology measurements reveal a time-dependent
increase in bone formation with and without silver coating,
which is associated with a signiﬁcant decrease in SSA and
marked thickening of trabeculae between the 2 and 6 week
samples (Figures 2b and c; Figure 4a). Trabecular thickening
and areas of contiguous ingrowth within either Ti or Ti−Ag
scaﬀolds is conspicuous, and 2D μCT images reveal pixel
intensities that are consistent with adjacent cortical bone from
12 week samples (Figures 2f and g and 3e and f). While
correlative imaging techniques employing μCT and histology to
quantify bone ingrowth in AM open-porous titanium implant50
are useful for conﬁrmation of tissue morphology at the
micrometer scale, these techniques have neither the resolution
nor the sensitivity to investigate nanoscale osseointegration and
uptake of metallic ions by regenerating bone. To address this
issue, correlative multimodal imaging was further augmented
using NanoSIMS and TEM to investigate elemental mapping of
the bone−implant interface across multiple length scales.
Medium resolution (∼10 μm) μCT imaging allowed non-
destructive 3D quantiﬁcation quantity of regenerated bone
within the porous implants. The higher resolution (∼3 μm) of
histological images permits reliable distinguishing of host and
regenerated bone in addition to other types of connective
tissue. The high lateral spatial resolution (∼200 nm) aﬀorded
by NanoSIMS allowed mapping with high elemental sensitivity
and resolution of thin trabecular bone (∼1 μm-thick) in the
vicinity of implants (Figures 6a, 7b, and 8g).
Bone growth occurs within the pores of the scaﬀold via thin
trabeculae (Figures 2b and c) as well as directly on the surfaces
of Ti and silver coated Ti implants (Figure 6b and g). These
two types of bone growth are termed distance (from defect to
implant surface) and contact (from implant surface to defect)
osteogenesis,56 respectively, and lead to bone formation in
opposite directions and faster osseointegration as evidenced
during the 2−12 week time points we examined (Figures 2b−
h). The extent of bone growth along titanium surfaces
(measured via bone contact percentage; Figure 3g) is not
signiﬁcantly diﬀerent between the Ti and Ti−Ag groups,
indicating that coating of Ti surfaces with AgNPs does not
impact osteoconduction within open-porous titanium implants.
Eriksson et al.57 employed time-of-ﬂight SIMS (TOF-SIMS),
ﬁnding that, after 4 weeks of implantation in rat tibiae,
hydroxyapatite fragments were present at the bone−implant
interface. In our study, strong signals from 40Ca16O− and
31P12C− were observed at 2 weeks postimplantation, providing
further conﬁrmation of contact osteogenesis on the surface of
Ti implants coated with AgNPs.
Silver Nanoparticle Sulﬁdation in Osseous Tissue.
NanoSIMS results indicate that by 2 weeks, silver from the
implant surface is released, and local dissemination results in
uptake by adjacent osseous tissue (Figure 7b(iv) and Figure 8f).
Figure 9. (a) TEM image of a region containing a silver coated titanium scaﬀold and surrounding tissue at 2 weeks postimplantation. The dotted line
delineates the interface between titanium implant and regenerated tissue. Inset (from boxed area) is a histological image of an electron transparent
tissue region adjacent to the implant that shows mineralized bone (stained green) next to ﬁbrous connective tissue (stained orange). Higher
magniﬁcation TEM images (b and c) from the area of bone identiﬁed in the inset reveals distinctive ∼10 nm width ﬁbrillar structures (yellow
arrowheads) and nano-particles (red arrowheads). The association of the ﬁbrillary structures with the electron dense particles is conspicuous (c).
SAED pattern of the encircled area in panel b was performed using a selected area aperture size of ∼400 nm. The concentric rings (d) imply the
presence of a crystalline nanoparticulate phase. The SAED pattern observed matches the standard silver sulﬁde pattern (dotted arc line in red),
strongly supporting the hypothesis that the particles in the TEM images are silver sulﬁde. Scale bars are 10 μm in panel a and the inset. The other
scale bars are (b) 100 nm, (c) 20 nm, and (d) 5 nm−1 (in reciprocal space).
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Macrophages, the primary phagocytic cell, arrive after 24−72 h
at the site of bone injury and are capable of rapidly solubilizing
metallic silver extracellularly and then accumulating silver−
sulfur nanocrystals within minutes in lysosome-like structures
in vitro.33 A similar process has been observed following
ingestion of silver coated nanowires by human type 1 alveolar
epithelial cells, suggesting that complexing of silver−sulfur is a
possible detoxiﬁcation mechanism for short-term accumulation
of free Ag+.34 A recent study demonstrated that the formation
of silver sulﬁde nanocrystals mediated through strongly
adsorbed protein coronas on silver nanoparticles leads to
reduced toxicity.35 Because the silver we detected in this study
was associated with sulfur, it is likely that a similar pathway of
detoxiﬁcation occurs in regenerated bone tissue adjacent to the
implant surface. This mechanism is consistent with our data
showing colocalization of silver with sulfur (Figure 7b(v), and
our TEM and SAED results showing its biotransformation to
silver sulﬁde nanoparticles (Figures 9b and c and SAED Figure
9d) over large sections of bone tissue. The combined
NanoSIMS and TEM/SAED results provide strong evidence
of the mechanism by which AgNP detoxiﬁcation occurs within
regenerating bone. The association of silver sulﬁde only within
the osseous tissue could be explained by the abundance of
sulfur containing proteins (i.e., albumin)58 and/or sulfur
compounds (i.e., H2S) generated during tissue forma-
tion.34,59−61
Because silver sulﬁde is less soluble than silver ions, the
eﬀective antimicrobial activity of the silver-coated implants will
be inﬂuenced by the biotransformation process. However,
further study is required to investigate the eﬃcacy, mode and
mechanism of antimicrobial action.
The measured SAED pattern (Figure 9d, dashed red lines)
closely matches the theoretical nanocrystalline Ag2S pattern.
62
However, some elemental silver was also indexed, and
unindexed lines suggest the presence of other crystalline
species such as hydroxy apatite. In addition to this, artifacts
introduced during sample preparation (e.g., material sputtered
from other regions) will also complicate the analysis.
Distinctive ∼10 nm width ﬁbrillar structures (yellow arrow-
heads, Figures 9b and c) are also visible, which we hypothesize
to be collagen type I, as it is observed in the newly regenerated
bone.
In vitro, the uptake of silver is considered harmful due to the
internalized AgNPs being released as silver ions,63 which could
generate reactive oxygen species (ROS) and cause cell death.29
Of signiﬁcance is that AgNPs are actively endocytosed by
numerous human cell types such as mesenchymal stem cells
(MSC),31 alveolar epithelial type I cells,34 HaCaT keratino-
cytes,25 and peripheral blood mononuclear cells (PBMC)26
consistent with the hypothesis that the endolysomomal
compartment is the route for detoxiﬁcation of silver in vitro.
Additionally, it is well-described that the eﬀects of AgNPs are
dependent on both their size and cell type being investigated in
vitro: for example, low concentrations of smaller size particles
(around 50 nm) (similar to the particle size observed on the
surface of our ALD coated Ti-implants) are relatively benign in
L929 ﬁbroblasts,28 hMSC,26,31 human PBMC,26 and HaCaT
keratinocytes.25 However, at high concentrations, small size
AgNPs are toxic, as demonstrated in 2 human osteosarcoma
cell lines,30 mouse primary osteoblast and osteoclasts,27 and
hMSC.29
In vivo studies examining administration via various routes
(inhalation, intravenous, and intraperitoneal) have also high-
lighted the importance of dose and AgNP size to their toxicity.
Inhalation of lower doses of AgNPs results in no measurable
genotoxicity in bone marrow.64 High doses of orally
administered AgNPs result in accumulation in the kidneys as
well as liver damage65 in addition to quantiﬁable bone marrow
cell genotoxicity.66 Similarly, intravenous or intraperitoneal
delivery of a high dose of AgNPs results in an increased
frequency of polychromatic erythrocytes in bone marrow,67
functional suppression of the immune system,68 or a combined
hepatotoxicity and genotoxicity.69 When AgNPs are dispersed
within DL-lactic-co-glycolic acid,70 incorporated into nano-
tubes,71,72 or immobilized on Ti73 prior to implantation into
bone, the scaﬀolds are osteoconductive, well-integrated, and
show antimicrobial activity and no evidence of toxicity. Similar
to these aforementioned studies, the AgNP particle size we
used in our in vivo analysis was both small (∼43 nm average)
and restricted to the area of regenerating bone adjacent to the
implant, resulting in excellent osseointegration with no signs of
toxicity.
5. CONCLUSIONS
Our in vivo experiments enabled the assessment of bone tissue
regeneration within an uninfected rat tibia defect in response to
an antimicrobial silver nanoparticle surface coating. The silver
nanoparticle-coated porous titanium implants showed bone
formation and osseointegration comparable to that of the
uncoated implants following 2−12 weeks of implantation.
Correlative imaging with NanoSIMS, histomorphometry, and
3D X-ray microcomputed tomography was used to analyze
silver content in tibiae implanted with these scaﬀolds. The
results demonstrated that silver accumulation primarily occurs
within the osseous tissue immediately adjacent to the surface
and was colocalized to sulfur. Transmission electron micros-
copy and selected area electron diﬀraction patterns reveal the
sulﬁdation of silver, forming less toxic Ag2S nanoparticles
within the newly formed bone.
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